Strategic M&A & Portfolio Growth Manager

Fresenius Kabi USA; United States; Hybrid; USD 138.000 - 150.000; Vollzeit

Benefits dieser Stelle

401(k) with company contributions

Paid vacation

Health benefits

Zusammenfassung

Fresenius Kabi USA is seeking a Manager for Corporate Portfolio and M&A to drive growth through inorganic and organic initiatives. The role involves identifying targets, leading due diligence, and coordinating with global teams for execution.

Regular interactions with management and cross functional leaders will shape strategic direction. The position supports travel to the Lake Zurich, IL headquarters and is eligible for an annual bonus with a 10% target.

Qualifikationen

• Bachelor’s degree in a scientific/technical/finance field required.
• MBA strongly preferred.
• 5+ years of experience in Business Development, M&A, Strategy and business analytics functions; 3+ years in healthcare.

Aufgaben

• Analyze markets, segments, sectors, companies/assets including startups across Fresenius business areas and identify targets for inorganic growth.
• Lead project management with cross functional teams to deliver corporate projects through due diligence, business case development, board approvals and execution.
• Prepare pitch documents for management to align and prioritize inorganic targets.
• Manage internal strategic corporate portfolio analysis and recommend new business areas and target evaluations.

Kenntnisse

Financial statements

Communication skills

MS Excel/PowerPoint

Ausbildung

Bachelor’s degree in scientific/technical/finance

MBA

Jobbeschreibung

Fresenius Kabi USA is seeking a Manager for Corporate Portfolio and M&A to drive growth through inorganic and organic initiatives. The role involves identifying targets, leading due diligence, and coordinating with global teams for execution.

Regular interactions with management and cross functional leaders will shape strategic direction. The position supports travel to the Lake Zurich, IL headquarters and is eligible for an annual bonus with a 10% target.